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Abstract 
Objectives: Previous studies have shown that smokers presented with ST-segment elevation 
myocardial infarction (STEMI) a decade earlier than non-smokers. However no account has 
been made for population smoking trends; an important deficit addressed by this study. 
Methods: The combination of admission data on patients with acute STEMI undergoing PCI 
and demographic data supplied by the Office for National Statistics for the South Yorkshire 
population between 2009-2012 were analysed to generate incidence rates and rate ratios (RR) 
to quantify the relative risk of STEMI from smoking, overall and by age group. 
Results: There were 1,795 STEMI patients included of which 72.9% were male. 68 patients 
were excluded as they had no smoking status recorded leaving 48.5% of the remaining 
population as current smokers, 27.2% ex-smokers and 24.3% never smokers. Smokers were 
over-represented with overall smoking prevalence in South Yorkshire calculated at 22.4%. 
The incidence of STEMI in smokers aged under 50, 50-65 and over 65 years was 59.7, 316.9 
and 331.0 per 100,000 patient years at risk compared to 7.0, 60.9 and 106.8 for the combined 
group of ex- and never smokers. This gave smokers under the age of 50 an 8.47 (95% CI: 
6.804-10.542) increase in rate compared to non-smokers of the same age, with 50-65 and 
greater than 65s having RR of 5.20 (95% CI: 4.761-5.689) and 3.10 (95% CI: 2.669-3.599) 
respectively. 
Conclusions: Smoking was associated with an eight fold increased risk of acute STEMI in 
younger smokers, when compared to ex- and never smokers. Further efforts to reduce 
smoking in the youngest are needed. 
Keywords: Smoking, acute ST-segment elevation myocardial infarction, risk factor, 
prevention.  
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What is already known about this subject? 
Smoking is a recognised and important cardiovascular risk factor that as of yet has not been 
quantified using incidence rate ratio analysis in different age groups.  
What does this study add? 
This study specifically looks at incidence rate ratios of acute STEMI and shows that smoking 
is associated with an increased incidence in acute STEMI for all ages, but this is greatest in 
the youngest smokers compared to their age-matched non-smoking counterparts. 
How might this impact on clinical practice? 
The cause of the differing risks from cigarette smoking on younger and older smokers 
remains unclear. All current smokers must be encouraged into smoking cessation therapy to 
reduce their risk of acute STEMI, with a focus on the youngest smokers whose increased risk 
is often unrecognised.  
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INTRODUCTION 
Cigarette smoking was first identified as a risk factor for cardiovascular disease with the 
Framingham Heart Study of the 1950s (1, 2). This landmark project was one of the first, 
alongside Doll and Hill (3, 4) to publicise the ill-effects of smoking. Large epidemiological 
studies have since demonstrated the link between tobacco smoking and acute myocardial 
infarction (AMI) and have established that smokers present at an earlier age than non-
smokers. In particular the National Registry of Myocardial Infarction 2 (NRMI2) found that 
smokers presenting with AMI were on average 14 years younger than non-smokers (5) and 
the Multinational Monitoring of trends and determinants in cardiovascular disease (MONICA) 
trials showed that prevalence of smokers was up to 81% in young patients aged 35-39 with 
AMI (6).  
However, there remains uncertainty as to the magnitude of the effect of tobacco smoking on 
the younger smoker. No study has compared the incidence of STEMI within young smokers 
and young non-smokers by using local population data as a denominator. This is likely due to 
a lack of comparative analysis of local population data with the population suffering a 
STEMI. This study was carried out to provide a clear incidence analysis and to quantify the 
risk of acute STEMI in the South Yorkshire region of the United Kingdom. 
 
METHODS 
Participants 
To calculate incidence analysis of STEMI in South Yorkshire, this study analysed two 
populations. The first was the case data of all South Yorkshire patients over the age of 18 
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who underwent percutaneous coronary intervention (PCI) for acute STEMI at the South 
Yorkshire Cardiothoracic Centre, Sheffield, United Kingdom. A continuous population 
between 1/1/2009 and 6/4/2012 of patients aged 18 and over were studied. The second data 
set was derived from responses from South Yorkshire residents aged 18 and over 
participating in the Office for National Statistics Integrated Household Survey (ONS-IHS) 
between April 2009 and March 2012 (7). 
Procedures 
Each patient included in the STEMI cohort had full demographic, risk-factor and procedural 
information collected from the individual hospital case records and the hospital database. 
6PRNLQJVWDWXVZDVUHFRUGHGDV³FXUUHQWVPRNHU´³H[-VPRNHU´RU³QHYHUVPRNHU´.  An ex-
smoker did not have a minimum duration of cessation needed to fit into this category, 
although when data was available, duration of cessation was recorded. This was due to 
difficulties in obtaining the smoking cessation duration, as this was not routinely recorded in 
admission documentation. In a small number of cases there was insufficient record keeping of 
the smoking status, and these were excluded from the rate ratio incidence analysis. 
Previous medical history of ischaemic heart disease, hypertension, diabetes, dyslipidaemia, 
transient ischaemic attack/stroke, peripheral vascular disease, and family history of ischaemic 
heart disease (IHD) were recorded.  
The ONS-IHS uses a multi-stage population weighting procedure which accounts for 
probability of selection and adjusts for non-response, enabling responses from South 
Yorkshire ONS-IHS to be weighted to represent the entire South Yorkshire population (7). 
As this weighting is specific to the period the ONS-IHS data is collected it also accounts for 
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people entering or leaving the population. Therefore, this data was presented as patient year 
at risk to most accurately reflect the open and changing population. 
Statistical methods 
Univariate categorical analysis of risk factors across smoking status within the STEMI cohort 
was performed using the Chi-Squared test, with multivariate adjustment for age using logistic 
regression.  
The incidence rate of STEMI in South Yorkshire was calculated using the STEMI and ONS-
IHS populatioQVXVLQJWKHIROORZLQJHTXDWLRQ³3HUVRQ-WLPHDWULVN´LVPHDVXUHGLQSDWLHQW-
years, and represents the true time that each patient spent in this at risk population. For 
example, a person who moved into the geographical area served by the South Yorkshire 
Cardiothoracic service part way through the study would have fewer person-time at risk, 
compared to a person who always lived in the catchment area. 
 ൌ  െ   
Rate ratios were used to compare incidence rates of STEMI between different groups (e.g. 
smokers and non-smokers). 
 ൌ   െ  
Analyses were performed with Stata 12.1 (STATA Corp, Texas) and SPSS software 23 
(IBM).
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RESULTS 
A total of 1,795 patients were included in the STEMI data. In 68 (3.8%) patients, the smoking 
status was unobtainable and was excluded from incidence analysis. The mean age of patient 
was 63.0 years (95% CI 62.38-63.56) and 72.9% of the population was male.  
Just under half of the population with known smoking status were current smokers (48.5%). 
At presentation, the mean age of the current smokers was 57.4 years (95% CI 56.63-58.13) 
which was around 10-11 years less than ex- and never smokers (ex-smokers: 68.5 years, 95% 
CI=67.48-69.61 and never smokers: 66.7 years, 95% CI=65.50-67.84.)  
ONS-IHS data allowed calculation of smoking prevalence rates for the South Yorkshire area, 
as shown by age group in figure 1. With this population, the highest prevalence of current 
smoking was found in those under the age of 50 (27.3%). However, this was much higher in 
those under the age of 50 who had suffered an acute STEMI (74.8%).  
Risk factor profiles of current, ex- and never smokers 
Logistic regression analysis allowed further study of the likelihood of risk factors being 
present in those who were current or ex-smokers compared to those patients who have never 
been exposed to cigarette smoking (table 1). Current smokers presenting with STEMI 
requiring PCI were less likely to have hypertension or diabetes, but more likely to have a 
family history of IHD (p<0.05 for all three). However, after adjusting for age, the differences 
in the odds of these risk factors were not statistically significant. Ex-smokers and current 
smokers were more likely than never smokers to have a previous history of IHD, including 
after adjustment for age OR=2.37, 95% CI 1.69-3.31, p<0.001 and OR=1.45, 95% CI= 1.03-
2.05, p<0.05 respectively). Lastly, current smokers were three times more likely than never 
smokers to suffer with peripheral vascular disease (OR=3.44, 95% CI 1.56-7.59, p<0.005). 
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Table 1 - Unadjusted and age-adjusted odds ratios for risk factors across smoking groups 
 
Age unadjusted risk factor prevalence Age-adjusted risk factor prevalence (odds ratio) 
 
Current Smoker Ex Smoker Never Smoker P Current Smoker Ex Smoker Never Smoker 
Risk Factor n=838 n=470 n=419 
 
   
Hypertension 285 (34.0%) 
209 
(44.5%) 
178 
(42.5%) <0.001 
0.88 
(0.69-1.14) 
p=0.337 
1.03 
(0.79-1.36) 
p=0.803 
1 
Previous history of 
IHD 
139 
(16.6%) 
138 
(29.4%) 
61 
(14.6%) <0.001 
1.45 
(1.03-2.05) 
p=0.035 
2.37 
(1.69-3.32) 
p<0.001 
1 
Diabetes 87 (10.4%) 
74 
(15.7%) 
60 
(14.3%) 0.012 
0.72 
(0.50-1.04) 
p=0.080 
1.11 
(0.77-1.61) 
p= 0.580 
1 
Dyslipidemia 316 (37.7%) 
209 
(44.5%) 
163 
(38.9%) 0.051 
0.90 
(0.70-1.16) 
p=0.431 
1.27 
(0.97-1.66) 
p=0.080 
1 
Family History of IHD 382 (45.6%) 
184 
(39.1%) 
166 
(39.6%) 0.033 
0.87 
(0.68-1.13) 
p=0.306 
1.06 
(0.81-1.40) 
p=0.664 
1 
Previous TIA/Stroke 45 (5.4%) 
35 
(7.4%) 
22 
(5.9%) 0.251 
1.59 
(0.91-2.77) 
p=0.106 
1.36 
(0.78-2.36) 
p=0.283 
1 
Peripheral Vascular 
Disease 
34 
(4.1%) 
18 
(3.8%) 
9 
(2.1%) 0.206 
3.44 
(1.56-7.59) 
p=0.002 
1.67 
(0.74-3.78) 
p=0.218 
1 
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Incidence of acute STEMI in South Yorkshire 
Ex-smokers and never smokers had similar incidence rates of acute STEMI, whereas this was 
much higher in the current smokers (Figure 2). This peaked in the 60-69 year old age group 
with an incidence rate of over 350 cases per 100,000 patient years at risk. By comparison, the 
peak age for incidence of STEMI in ex- and never smokers was 10 years later, in the 70-79 
year age group, with over 100 cases per 100,000 patient years at risk. 
Incidence rate ratio analysis 
Rate ratio analysis to compare incidence rates between current smokers, and their age-
matched ex- and never smoking counter-parts was performed (Figure 3). Although not 
statistically significant for risk factors other than a previous history of IHD, ex-smokers 
tended towards higher odds for each risk factor than never smokers.  Combining these two 
groups therefore provides a more conservative estimate of the comparison with current 
smokers than comparing to never smokers alone. This analysis showed that for all ages, 
current smokers were 3.26 (95% CI 2.98-3.57) more likely to suffer acute STEMI than ex- 
and never smokers grouped together. Stratification by age group showed the highest rate ratio 
in the youngest age group analysed. Current smokers, under 50 years were 8.47 (95% CI 
6.80-10.54) times more likely to suffer an acute STEMI compared to their age-matched ex- 
and never smokers. The incidence rate ratio subsequently decreased in the older age groups. 
Those aged 50-65 years had a RR of 5.20 (95% CI 4.76-5.69) and those aged over 65 years 
the RR=3.10 (95% CI=2.67-3.60). 
DISCUSSION 
The main finding of this study is that for all age groups, current smokers were over three 
times more likely to have an acute STEMI than the comparison group, comprising of ex- and 
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never smokers. Although previous studies have demonstrated a significant increase in risk of 
AMI in smokers, our analysis is the first to quantify this risk using incidence rate ratio 
analysis (8-12) The detrimental effect of smoking was most marked in the younger age group; 
smokers under 50 years of age had more than 8 times the risk of an acute STEMI, compared 
to their age-matched ex- and never smokers. 
In this incidence analysis of STEMI patients the population was predominantly male and 
smoking prevalence was higher in the younger age groups. There was a mean age difference 
of 10-11 years between current and non-smokers. These results mirrored other large AMI 
studies (10, 13-14). However, one other AMI reported an even larger 14 year age difference 
(5).  
Ex- smokers and never smokers share similar incidence rates of STEMI 
Incidence rate analysis clearly shows that smokers who quit or those have never smoked have 
a significantly lower incidence rate of acute STEMI. Of note is the similarity of incidence of 
acute STEMI between ex- smokers and never smokers. Both ex- smokers and never smokers 
presented at similar ages with acute STEMI, and the mean age difference was not statistically 
significant (ex-smoker mean age 68.54; 95% CI= 67.48-69.61, never smoker mean age 66.67; 
95% CI=65.50-67.84). This data indicates that giving up smoking reduces the incidence of 
acute STEMI to that of someone who has never smoked, in all age groups. One paper has 
suggested that ex-smokers can approach the same risk of a first or second MI as never-
smokers, but this benefit may be seen after 15 years of smoking cessation (9). However, 
another paper found an elevated risk of a major IHD event remained even at 20 years of 
smoking cessation (10). Undoubtedly however, smoking cessation is associated with marked 
reduction of coronary heart disease mortality (11).  
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Analysis of the risk factor profile of ex-smokers and never smokers may partly explain this 
similar incidence rate in the two groups. Other than a previous history of IHD, which was 
higher in ex-smokers, the risk factor profile between the two groups was largely similar. This 
may explain why similar levels of acute STEMI occurred. However, ex-smokers, who were 
much more likely to have a diagnosis of previous IHD, may have received secondary 
preventative therapy. It may also be a reflection of the benefits of smoking cessation 
regardless of duration of the cessation period, although this was not measured in this study. 
Those who are youngest experienced the greatest risk from smoking 
Using the incidence rates of acute STEMI in different groups, incidence rate ratio analysis 
allowed comparison of risk associated with smoking across various age groups. A recent 
study explored the odds ratio (OR) of being a smoker in those who presented with STEMI 
across different age groups (12). Those in the youngest age group were the most likely to be 
smokers (11.4; 95% CI 10.0-12.8), compared to those aged over 65 whose OR peaked at only 
3.4 (95% CI 3.3-3.4). Our study examined this trend from a different angle, using current, ex- 
and never smokers as the starting points, and using incidence analysis to calculate their risk 
of STEMI across different age groups conferred by their smoking.  
From this analysis, we found that those who were under the age of 50 years had the highest 
likelihood of acute STEMI attributable to their smoking, compared to their age matched ex- 
and never smokers. Indeed, this group was over eight times more likely to suffer an acute 
STEMI. The older age groups did not appear to confer such a high risk from their smoking 
when compared to age-matched ex- and never smokers. Those aged 50-65 years were over 
five times more likely to suffer an acute STEMI and those aged over 65 years were over three 
times as likely. The MONICA trials found similar results: those who were young and smoked 
were more at risk and that the relative risk associated with smoking decreased with the ageing 
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groups, a trend mirrored in our data (6). The INTERHEART study also looked at the risk 
profiles across age groups and reported that younger smokers compared with age matched 
never smokers experienced a larger effect from current smoking  (OR=3·53, 95% CI 3.23±
3.86) with respect to increased risk to AMI than in older individuals. However, these studies 
predated the newer AMI classification and did not identify acute STEMI patients in particular. 
From our data alone, it is difficult to explain the much higher risk of acute STEMI imparted 
by smoking on the youngest patients and raises important questions as to why this should 
occur. It is recognised that the youngest populations tend to demonstrate fewer risk factors 
such as hypertension, hyperlipidaemia or diabetes and this has been demonstrated in young 
STEMI patients who smoke (15). Therefore, smoking appears to be much more potent risk of 
STEMI in the young, as it is one of very few risk factors present in this group. The GRACE 
registry reported that smokers presented with ACS with a much more favourable risk profile, 
and as smokers were on average around 10 years younger than non-smokers, this may 
support the above theory (8). Whilst other studies concur that smoking prevalence is higher in 
younger age groups with myocardial infarction, other risk factors have also been identified as 
more prevalent in younger age groups, such as family history of CAD and hyperlipidaemia (5, 
16-18). 
The high rate ratio seen in the youngest smokers may indicate that smoking is perhaps the 
most powerful of all risk factors, exerting its effect much sooner than any other. This is 
supported by other studies which identified smoking as not only the most prevalent, but also 
one of the most important risk factor in the young (16).  
Recent evidence suggests that the histological composition of plaque differs between smokers 
and non-smokers (19). Cigarette smokers appear to be more vulnerable to arterial plaque 
rupture due to the higher burden of a necrotic core (20.7% vs 17.2% in non-smokers; p=0.04). 
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This suggests that smoking may induce plaque instability. In addition, a recent study has 
demonstrated an unexpected finding that post-STEMI smokers have not demonstrated a 
significant reduction in the risk of all-cause mortality (15), despite receiving evidence based 
therapies. This strengthens the argument for a focus on prevention of smoking in the 
youngest age groups. 
Older age groups experience less risk from smoking 
Whilst an increased risk of acute STEMI persisted in older current smokers (RR=3.10), it was 
much lower than what is seen in the younger age groups (RR=8.47). The epidemiological 
landscape of risk factors in the older patients is more complex, and cardiac risk factors are 
more prevalent. Therefore, it may be expected that the incidence of STEMI across the whole 
population would increase similarly for the ex-, never and current smokers, thus diluting the 
detrimental effect smoking seen in the youngest age group. This can be demonstrated by the 
steadily increasing incidence rate of acute STEMI of ex- and never smokers with age (figure 
2) and the subsequent lower rate ratio in the oldest age groups.  
Interestingly, incidence of STEMI in current smokers decreases markedly between the ages 
of 70-79, which contributed to the smaller rate ratio seen in the older current smokers. There 
may be a few reasons for this decrease. Firstly, there may be some element of survival bias. 
Those who were current smokers may have died, decreasing the incidence of acute STEMI in 
this group, resulting in a distorted representation of this outcome. Secondly, it may be that 
plaque composition changes, which occur over time, may have a direct bearing on incidence 
of acute STEMI, as the plaques become more calcified and less vulnerable in older patients.  
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Study strengths 
The study accurately determined the incidence of STEMI in South Yorkshire using data on 
smoking prevalence within this region. By comparing the smoking habits of patients with an 
acute STEMI to that of the general population of the area we have not only reported an 
increased smoking prevalence in the young, but also quantified the risk this habit imparts 
upon them. This can guide health policy on targeting the most important groups to promote 
preventative measures. This study may also help to tackle the misconception by young 
smokers that acute STEMI is a disease of the elderly, by showing that this group is very 
vulnerable and has the highest risk from their smoking. 
Study limitations 
This study is based on retrospective analysis of prospectively collected data. Whilst the 
inclusion criteria for this study are broad, only those suffering an acute STEMI who 
underwent PCI at the South Yorkshire Cardiothoracic Centre were studied. Patients who died 
before admission or who were deemed unsuitable for PCI, were not included in the analysis. 
Although we do not have exact data, we would highlight that the well-established and 
monitored primary PCI service in South Yorkshire successfully identifies and refers nearly all 
patients with acute STEMI to the South Yorkshire Cardiothoracic Centre. It is rare for a 
patient to be excluded from such proven treatment and the alternative (and less effective) 
thrombolytic therapy has now been largely forgotten. It is also rare for a patient, who may be 
experiencing severe chest pain and feeling very unwell, to refuse to give their consent to 
undergo primary PCI. We estimate that fewer than 1% of patients would be excluded for 
these reasons. 
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CONCLUSIONS 
This is the first study to use population data combined with case data to conclusively show 
that rate ratios are much higher in younger smokers compared with older smokers in acute 
STEMI. The difference between the ages is striking: young smokers are over 8 times more 
likely to suffer acute STEMI compared with age matched counterparts, whereas those aged 
50-65 are just 5 times as likely and those aged 65 and over only 3 times more likely.
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LIST OF ABBREVIATIONS 
 
AMI Acute myocardial infarction 
IHD Ischaemic heart disease 
MI Myocardial infarction 
ONS-IHS Office for national statistics integrated 
household survey 
PCI Percutaneous coronary intervention 
STEMI ST-segment elevation myocardial infarction 
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FIGURE LEGENDS 
Figure 1 Smoking prevalence (%) within the STEMI cohort and in South Yorkshire derived 
from ONS Integrated Household Survey (IHS) responses. Weighted patient years for the IHS 
are presented, with unweighted responses reported in brackets. 
Figure 2 Incidence of acute STEMI by smoking status in South Yorkshire, calculated using 
patient time from the Office of National Statistics Integrated Household Survey and a cohort 
of patients presenting with STEMI. Current smokers had a peak incidence of acute STEMI at 
age 60-69, whereas for ex- and never smokers, the peak incidence was 10 years later at 70-79 
years. 
Figure 3 Rate ratios of smokers compared to ex/never smokers for the incidence of acute 
STEMI by age group, calculated using patient time from the Office of National Statistics 
Integrated Household Survey and a cohort of patients presenting with STEMI. Those in the 
youngest age group <50 years had the highest likelihood of an acute STEMI conferred by 
smoking (RR=8.47). The risk conferred by smoking on acute STEMI was lowest in the oldest 
age groups. 
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